Belpointe Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,750	Closed	-$102K	–	3104
2023 Q1	$102K	Buy	6,750 +4,654	+222%	+$70K	0.01%	1298
2022 Q4	$24.8K	Buy	+2,096	New	+$24.8K	﹤0.01%	2031
2018 Q4	–	Sell	-43,435	Closed	-$243K	–	629
2018 Q3	$243K	Buy	+43,435	New	+$243K	0.04%	407